We are excited to share that Cytel has formed a strategic partnership with OneMedNet (ONMD), a pioneer in clinical and imaging Real-World data solutions. This collaboration marks a significant step forward in our commitment to advancing human data science through innovative analytics and insights.

Our partnership with OneMedNet will integrate their robust clinical and extensive imaging Real World Data platform for over 121M clinical exams from over 1,400 U.S. locations with our advanced analytics capabilities. This synergy will enable customers in the biotech and pharma sectors to access ONMD’s data via Cytel’s Fit For Purpose Data Tool^TM, fostering innovation in trial design, observational studies, and development of AI/ML models.  The combined clinical and imaging data is specifically tailored to meet the analytics needs of sponsors across multiple therapeutic areas including neurologic disorders, oncology, and cardiology.

Massoud Toussi, Vice President, Global Head of Real-World Evidence expresses: “As a human data science company, we’re thrilled to announce our strategic partnership with OneMedNet. Their unique access to data from imaging devices, combined with their innovative iRWD platform for collecting additional clinical data, aligns perfectly with our mission. This collaboration will empower us to deliver additional valuable solutions to our clients and drive meaningful impact in our industry.”

By leveraging OneMedNet’s comprehensive longitudinal clinical and imaging regulatory-grade data, we are well-positioned to fill significant gaps in healthcare data and enhance the precision of medical analysis and healthcare delivery.

For more information about this partnership or to explore how it can benefit your organization, please contact us at marketing@cytel.com.

Stay tuned for updates on this exciting journey as we continue to redefine the landscape of data-driven healthcare solutions.

Share Via